Nucleus Software Exports Limited announced its financial results for the quarter and nine months ended December 31, 2025, presenting a mixed performance with revenue growth offset by profit decline due to exceptional charges.

Financial Performance Overview

The company's consolidated financial results showed contrasting trends in revenue and profitability metrics for the third quarter of FY26.

Exceptional Items Impact

The company recorded a significant exceptional charge of Rs 1,885 lacs during the quarter related to the implementation of new Labour Codes. This charge comprised:

• Increase in gratuity liability due to past service cost: Rs 1,349 lacs
• Increase in compensated absences liability: Rs 536 lacs

The Labour Codes, notified by the Government of India on November 21, 2025, consolidate twenty-nine existing labour laws and introduce changes including uniform wage definitions and enhanced leave benefits.

Standalone Performance

The standalone financial results also reflected similar trends with revenue growth but profit decline.

Geographical Revenue Distribution

The company's revenue streams showed varied performance across different geographical segments for Q3FY26:

• India: Rs 13,109 lacs (largest contributor)
• South East Asia: Rs 2,574 lacs
• Middle East: Rs 2,224 lacs
• Others: Rs 1,529 lacs
• Europe: Rs 928 lacs
• Far East: Rs 815 lacs
• Australia: Rs 573 lacs
• Africa: Rs 251 lacs

Expense Analysis

Total consolidated expenses increased to Rs 19,164 lacs in Q3FY26 from Rs 17,627 lacs in Q3FY25. Key expense components included:

• Employee benefits expense: Rs 14,486 lacs
• Operating and other expenses: Rs 4,195 lacs
• Depreciation and amortisation: Rs 433 lacs
• Finance cost: Rs 50 lacs

Board Meeting and Audit

The Board of Directors approved the audited standalone financial results and unaudited consolidated financial results at their meeting held on February 10, 2026. The meeting commenced at 10:00 a.m. and concluded at 2:10 p.m. The financial results were duly reviewed by the Audit Committee and received unmodified audit opinion and review conclusion from statutory auditors ASA & Associates LLP.

Nucleus Software Exports Limited has announced the appointment of Dr. Apurva Chamaria as Chief Business Officer effective February 02, 2026. The company disclosed this strategic appointment through a press release to stock exchanges under Regulation 30 of the Securities and Exchange Board of India regulations.

Appointment Details

The appointment details are outlined in the company's regulatory filing:

Strategic Leadership Addition

Commenting on the appointment, Parag Bhise, CEO & Executive Director of Nucleus Software, emphasized the strategic importance of this hire: "As we continue to scale our operations and expand our global footprint, getting an impactful leaders to be part of this journey is paramount. Dr. Apurva brings exceptional strategic thinking, deep industry knowledge, and a customer-first approach that will be invaluable as we pursue our next phase of growth."

Dr. Apurva Chamaria expressed his enthusiasm about joining the company: "I am excited to join Nucleus Software at this pivotal moment in the company's journey. The opportunity to work with a talented team, industry-leading solutions, and a diverse global client base is truly compelling. I look forward to contributing to Nucleus Software's growth trajectory and helping our customers navigate their business challenges in an AI first world with confidence and success."

Professional Background and Experience

Dr. Apurva Chamaria brings extensive leadership experience spanning over 23 years across diverse functions including sales, marketing, partnerships, business development, and mergers & acquisitions. His career trajectory includes senior roles at several respected organizations in India's corporate landscape.

Career Highlights

Dr. Chamaria's professional journey encompasses leadership positions at:

• Google: Most recently served as Global Head of Startups, VC & Private Equity Partnerships
• RateGain: Previously held the position of Chief Revenue Officer, where he achieved significant revenue growth
• Tech Mahindra: Contributed to the company's business development initiatives
• HCL Technologies: Gained experience in technology sector operations
• Ranbaxy: Early career experience in pharmaceutical industry

Educational Qualifications and Recognition

Dr. Chamaria's academic credentials reflect a comprehensive educational background from premier institutions. He is an alumnus of Mayo College, IIT Delhi, IIMC, IMI and Harvard Business School. His international exposure includes professional experience across multiple countries including the United States, United Kingdom, South Africa, Australia and India.

Industry Recognition

His contributions to the industry have earned him several notable recognitions:

• Named Campaign Asia 40 under 40
• Honored as Fellow of the All-India Management Association (AIMA) in 2020
• Member of Young Presidents Organization (YPO)
• Author of two bestselling books published by Bloomsbury and Penguin Random House

Strategic Impact and Growth Focus

The appointment comes at a time when Nucleus Software is experiencing strong momentum in cloud-native lending solutions, transaction banking platforms, and AI-driven innovations for the BFSI sector. Dr. Chamaria will be responsible for driving business growth, deepening customer relationships, and advancing the company's expansion strategy across key markets.

This strategic appointment reinforces Nucleus Software's commitment to strengthening its leadership and scaling its business operations globally. His leadership will be instrumental in accelerating go-to-market strategies, strengthening partnerships, and expanding customer engagement across geographies.